Prot# VP-VEC-162-3106: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Investigate the Efficacy and Safety of Multiple Oral Doses of Tasimelteon and Matching Placebo in Travelers with Jet Lag Disorder

Project: Research project

Project Details

StatusFinished
Effective start/end date10/25/1610/25/17

Funding

  • Medpace, Inc. (VP-VEC-162-3106 // VP-VEC-162-3106)
  • Vanda Pharmaceuticals Inc. (VP-VEC-162-3106 // VP-VEC-162-3106)